Ken Fisher Lantern Pharma Inc. Transaction History
Fisher Asset Management, LLC
- $229 Billion
- Q2 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 10,000 shares of LTRN stock, worth $37,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$37,800% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LTRN
# of Institutions
41Shares Held
1.26MCall Options Held
42.8KPut Options Held
5.6K-
Vanguard Group Inc Valley Forge, PA364KShares$1.37 Million0.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA157KShares$593,9280.01% of portfolio
-
Geode Capital Management, LLC Boston, MA86.3KShares$326,3910.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.8KShares$309,2040.0% of portfolio
-
Cm Management, LLC80KShares$302,4000.35% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $40.9M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...